#Sarscov2

Isabella Eckerle

EckerleIsabella

A few explanations why I'm worried: The dynamic of #SARSCoV2 #B117 in the UK is concerning, taking over other strains at rapid speed even though incidence is high. Found in

BrinkmannLab

BrinkmannLab

Warum ist #SARSCoV2 so gefährlich – obwohl die meisten nicht schwer erkranken?Ein Thread.Sehr tödliche Viren wie das Ebola Virus zum Beispiel sind meist deutlich leichter einzudämmen als SARS-CoV-2. Warum ist

Dr Emma Hodcroft

firefoxx66

Gentle reminder that in Switzerland we are still feeling our way in the dark: with a #SARSCoV2 test positivity this high, the # of cases we report is largely linked

Eric Topol

EricTopol

Big news: The JNJ vaccine results of 44,000 Phase 3 trial, a single dose. Overall 66% efficacy, with the contrast of 72% in US but 57% in South Africa, confirming

Whitney R. Robinson

WhitneyEpi

1/ An #EpiTwitter about theory... https://twitter.com/theatlantic/status/1295469921233772547 2/ Many epidemiologists are not trained in social or health behavior theory. Its value is often overlooked in a field that values quantitative

Prof Francois Balloux

BallouxFrancois

Antibody-Dependent Enhancement (ADE) is a complex and poorly understood phenomenon, likely underpinned by different mechanisms, where binding of a virus to suboptimal antibodies enhances severity of the disease, rather than

Eric Feigl-Ding

DrEricDing

2) To be clear, we’ve known #SARSCoV2 is airborne (and known for a while now, despite deniers & downplayers). But the #b117 is even more transmissible. aerosol study indicates that

Ruminator Dan

RuminatorDan

PRE-EXISTING IMMUNITY TO #SARSCoV2:It is common these days to see mention of pre-existing immunity. A growing weight of evidence supports the idea. It is less common to have deduced this

Steven Kerfoot

SteveKerfoot

I don't know who needs to hear this, but:I've spent a bunch of time digging into this "new" #SARSCoV2 strain. I, and a bunch of very serious researchers who know

Laurie Garrett

Laurie_Garrett

Detailed assessment of the new UK #SARSCoV2 variant by @WHO scientific team: https://www.who.int/csr/don/21-december-2020-sars-cov2-variant-united-kingdom/en/Key points in thread. 2/ The @WHO takes a global view:"One of the mutations i

Nicholas A. Christakis

NAChristakis

Let’s talk about a COVID19 seroprevalence study, this time well conducted (it seems), which provides a petri-dish type natural experiment. It’s the small Austrian mountain ski village of Ischgl, one of the epicenters of SARSCoV2.

Alex Berenson

AlexBerenson

Florida: almost 400,000 #SARSCoV2 “cases” (positive tests) in the last six but the hospitals are emptier than they were on July 5, and #Covid hospitalizations are down 40% since peak...

Vinod Scaria

vinodscaria

Our recent preprint of genetic epidemiology of #immune #escape variants from global #SARSCoV2 genomeshttps://www.biorxiv.org/content/10.1101/2020.12.24.424332v1 A number of genetic variants in #SARSCoV2 are associated with immune escape - a

Alex Berenson

AlexBerenson

Great thread here. When they first calculated the #sarscov2 death rate, @neil_ferguson and the other geniuses behind this mess didn't bother to consider they were using a sample totally unlike

Alex Berenson

AlexBerenson

1/ Remember that time in February 2018 when a 38-year-old teacher in Dallas and a 38-year-old teacher in Atlanta both died of the flu within days of each other and

Jonathan Ball

JonathanKBall

Must confess to getting increasing concern about #sarscov2 #vaccine #effectiveness claims. The real data we need to see is either prevention of infection or reduction in transmission risk in lee-vulnerable

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.